923 related articles for article (PubMed ID: 30565180)
1. Short-Term Assessment of Intravitreal Dexamethasone Implant Using Enhanced-Depth Image Optical Coherence Tomography and Optical Coherence Tomography Angiography in Patients with Retinal Vascular Diseases.
Minnella AM; Federici M; Pagliei V; Lanza A; Gambini G; Caputo CG; Falsini B; Caporossi A
Adv Ther; 2019 Feb; 36(2):416-425. PubMed ID: 30565180
[TBL] [Abstract][Full Text] [Related]
2. SD-OCT pattern of retinal venous occlusion with cystoid macular edema treated with Ozurdex®.
Coscas G; Coscas F; Zucchiatti I; Glacet-Bernard A; Soubrane G; Souïed E
Eur J Ophthalmol; 2011; 21(5):631-6. PubMed ID: 21500185
[TBL] [Abstract][Full Text] [Related]
3. Optical coherence tomography angiography in retinal vein occlusion treated with dexamethasone implant: a new test for follow-up evaluation.
Glacet-Bernard A; Sellam A; Coscas F; Coscas G; Souied EH
Eur J Ophthalmol; 2016 Aug; 26(5):460-8. PubMed ID: 27405288
[TBL] [Abstract][Full Text] [Related]
4. Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study.
Dugel PU; Capone A; Singer MA; Dreyer RF; Dodwell DG; Roth DB; Shi R; Walt JG; Scott LC; Hollander DA;
BMC Ophthalmol; 2015 Sep; 15():118. PubMed ID: 26337664
[TBL] [Abstract][Full Text] [Related]
5. Changes in choroidal thickness after intravitreal dexamethasone implant injection in retinal vein occlusion.
Lee EK; Han JM; Hyon JY; Yu HG
Br J Ophthalmol; 2015 Nov; 99(11):1543-9. PubMed ID: 25883084
[TBL] [Abstract][Full Text] [Related]
6. Imaging retinal inflammatory biomarkers after intravitreal steroid and anti-VEGF treatment in diabetic macular oedema.
Vujosevic S; Torresin T; Bini S; Convento E; Pilotto E; Parrozzani R; Midena E
Acta Ophthalmol; 2017 Aug; 95(5):464-471. PubMed ID: 27775223
[TBL] [Abstract][Full Text] [Related]
7. Dexamethasone for unresponsive diabetic macular oedema: optical coherence tomography biomarkers.
Bonfiglio V; Reibaldi M; Pizzo A; Russo A; Macchi I; Faro G; Avitabile T; Longo A
Acta Ophthalmol; 2019 Jun; 97(4):e540-e544. PubMed ID: 30318792
[TBL] [Abstract][Full Text] [Related]
8. Effect of combination therapy with bevacizumab and dexamethasone intravitreal implant in patients with retinal vein occlusion.
Singer MA; Bell DJ; Woods P; Pollard J; Boord T; Herro A; Porbandarwalla S
Retina; 2012 Jul; 32(7):1289-94. PubMed ID: 22466480
[TBL] [Abstract][Full Text] [Related]
9. Dexamethasone intravitreous implant versus bevacizumab for central retinal vein occlusion-related macular oedema: a prospective randomized comparison.
Gado AS; Macky TA
Clin Exp Ophthalmol; 2014; 42(7):650-5. PubMed ID: 24612095
[TBL] [Abstract][Full Text] [Related]
10. INTRAVITREAL DEXAMETHASONE IMPLANT FOR THE TREATMENT OF REFRACTORY MACULAR EDEMA IN RETINAL VASCULAR DISEASES: Results of the KKESH International Collaborative Retina Study Group.
Alshahrani ST; Dolz-Marco R; Gallego-Pinazo R; Diaz-Llopis M; Arevalo JF;
Retina; 2016 Jan; 36(1):131-6. PubMed ID: 26079477
[TBL] [Abstract][Full Text] [Related]
11. Two-year, prospective, multicenter study of the use of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in the clinical setting in France.
Korobelnik JF; Kodjikian L; Delcourt C; Gualino V; Leaback R; Pinchinat S; Velard ME
Graefes Arch Clin Exp Ophthalmol; 2016 Dec; 254(12):2307-2318. PubMed ID: 27286894
[TBL] [Abstract][Full Text] [Related]
12. Ranibizumab versus Dexamethasone Implant in Macular Edema Secondary to Branch Retinal Vein Occlusion: Two-year Outcomes.
Ozkaya A; Tarakcioglu HN; Tanir I
Optom Vis Sci; 2018 Dec; 95(12):1149-1154. PubMed ID: 30451802
[TBL] [Abstract][Full Text] [Related]
13. Morphological and functional changes in recalcitrant diabetic macular oedema after intravitreal dexamethasone implant.
Iacono P; Parodi MB; Scaramuzzi M; Bandello F
Br J Ophthalmol; 2017 Jun; 101(6):791-795. PubMed ID: 27625164
[TBL] [Abstract][Full Text] [Related]
14. Use of intravitreal dexamethasone implant in patients with cataract and macular edema undergoing phacoemulsification.
Sze AM; Luk FO; Yip TP; Lee GK; Chan CK
Eur J Ophthalmol; 2015; 25(2):168-72. PubMed ID: 25363857
[TBL] [Abstract][Full Text] [Related]
15. Changes in macular function after ozurdex for retinal vein occlusion.
Querques G; Cascavilla ML; Cavallero E; Triolo G; Querques L; Lattanzio R; Cicinelli MV; Preziosa C; Borrelli E; Bandello F
Optom Vis Sci; 2014 Jul; 91(7):760-8. PubMed ID: 24927143
[TBL] [Abstract][Full Text] [Related]
16. The prevalence of vitreomacular adhesion in eyes with macular oedema secondary to retinal vein occlusion selected for intravitreal injections.
Maggio E; Maraone G; Mete M; Vingolo EM; Grenga PL; Guerriero M; Pertile G
Acta Ophthalmol; 2021 Nov; 99(7):e1154-e1161. PubMed ID: 33421346
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal Dexamethasone Implant versus Intravitreal Ranibizumab for the Treatment of Macular Edema Secondary to Retinal Vein Occlusion in a Chinese Population.
Gu X; Yu X; Song S; Dai H
Ophthalmic Res; 2017; 58(1):8-14. PubMed ID: 28334720
[TBL] [Abstract][Full Text] [Related]
18. HYPERREFLECTIVE FOCI AS AN INDEPENDENT VISUAL OUTCOME PREDICTOR IN MACULAR EDEMA DUE TO RETINAL VASCULAR DISEASES TREATED WITH INTRAVITREAL DEXAMETHASONE OR RANIBIZUMAB.
Chatziralli IP; Sergentanis TN; Sivaprasad S
Retina; 2016 Dec; 36(12):2319-2328. PubMed ID: 27258668
[TBL] [Abstract][Full Text] [Related]
19. CHOROIDAL THICKNESS CHANGES AFTER INTRAVITREAL DEXAMETHASONE IMPLANT INJECTION FOR THE TREATMENT OF MACULAR EDEMA DUE TO RETINAL VEIN OCCLUSION.
Esen E; Sizmaz S; Demircan N
Retina; 2016 Dec; 36(12):2297-2303. PubMed ID: 27870799
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of intravitreal dexamethasone implant as the first-line treatment for retinal vein occlusion-related macular edema in a real-life scenario.
Simsek M; Citirik M; Ozates S; Ozkoyuncu D
Indian J Ophthalmol; 2018 Jun; 66(6):831-836. PubMed ID: 29785994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]